Please enable JavaScript to continue using this application.

Compare $CDNA vs $PURR | Chartloom

Compare

$CDNA vs $PURR

CareDx Inc · Hyperliquid Strategies Inc

CDNA

CareDx Inc

PURR

Hyperliquid Strategies Inc

Compare $CDNA vs $PURR

Comparing CareDx Inc and Hyperliquid Strategies Inc

CDNACareDx Inc

PURRHyperliquid Strategies Inc

CDNACareDx Inc

Market cap

$3.29B

P/E (TTM)

30.64x

Forward P/E (NTM)

57.50x

Forward P/S (NTM)

6.55x

Rev growth (TTM)

34.4%

YTD performance

232.7%

52W performance

330.5%

FCF yield

2.6%

PURRHyperliquid Strategies Inc

Market cap

$1.50B

P/E (TTM)

—

Forward P/E (NTM)

54.46x

Forward P/S (NTM)

31.07x

Rev growth (TTM)

—

YTD performance

223.0%

52W performance

184.9%

FCF yield

-21.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CDNA

PURR

Detailed metrics comparison

CDNA

CareDx Inc

PURR

Hyperliquid Strategies Inc

Market Cap

CDNA$3.29B

PURR$1.50B

Enterprise Value

CDNA$2.92B

PURR$1.36B

Price

CDNA$63.67

PURR$11.11

P/E Ratio

CDNA30.64x

PURRN/A

P/S Ratio

CDNA7.18x

PURR478.45x

EV/Sales

CDNA6.36x

PURR434.33x

EV/EBITDA

CDNA23.24x

PURR0.00x

P/B Ratio

CDNA8.16x

PURR3.80x

P/FCF Ratio

CDNA39.14x

PURRN/A

EV/FCF

CDNA34.70x

PURR-4.21x

PEG Ratio

CDNA0.31x

PURRN/A

Forward P/E (NTM)

CDNA57.50x

PURR54.46x

Forward P/S (NTM)

CDNA6.55x

PURR31.07x

Revenue (TTM)

CDNA$458M

PURR$3M

Revenue Growth (YoY)

CDNA34.4%

PURRN/A

Forward Rev Growth

CDNA7.0%

PURR32.1%

Gross Margin (TTM)

CDNA70.6%

PURR0.0%

Operating Margin (TTM)

CDNA23.6%

PURR0.0%

EBITDA Margin (TTM)

CDNA27.4%

PURR-41799.5%

Net Margin (TTM)

CDNA24.2%

PURR-44523.2%

FCF Margin (TTM)

CDNA18.3%

PURR-10320.0%

Net Income (TTM)

CDNA$111M

PURR$-1.39B

FCF (TTM)

CDNA$84M

PURR$-323M

EPS (TTM)

CDNA$2.08

PURR-$8.94

ROE (TTM)

CDNA32.8%

PURR0.0%

ROA (TTM)

CDNA24.8%

PURR0.0%

ROIC (TTM)

CDNA32.8%

PURR0.0%

Cash

CDNA$374M

PURR$138M

Debt

CDNA$0

PURR$0

Net Cash/Debt

CDNA$374M

PURR$138M

Current Ratio (TTM)

CDNA4.58x

PURR41.62x

Quick Ratio (TTM)

CDNA4.35x

PURR37.77x

Debt/Equity (TTM)

CDNA0.00x

PURR0.00x

Debt/Assets (TTM)

CDNA0.0%

PURR0.0%

Interest Coverage (TTM)

CDNAN/A

PURRN/A

Net Debt/EBITDA (TTM)

CDNA0.00x

PURR0.00x

Beta

CDNA2.58

PURR1.09

52W Performance

CDNA330.5%

PURR184.9%

YTD Performance

CDNA232.7%

PURR223.0%

% from 52W High

CDNA-12.2%

PURR-24.7%

% from 52W Low

CDNA356.4%

PURR269.1%

Asset Turnover (TTM)

CDNA1.02x

PURR0.00x

FCF Yield (TTM)

CDNA2.6%

PURR-21.6%

Earnings Yield (TTM)

CDNA3.4%

PURR-93.1%

Dividend Yield (TTM)

CDNAN/A

PURRN/A

Rule of 40

CDNA52.7

PURR-10,320.0

EV/GP/RG

CDNA0.94

PURRN/A

Ticker research

View CDNA research View PURR research

Metric	CDNA CareDx Inc	PURR Hyperliquid Strategies Inc
Market & Valuation
Market Cap	$3.29B	$1.50B
Enterprise Value	$2.92B	$1.36B
Price	$63.67	$11.11
P/E Ratio	30.64x	N/A
P/S Ratio	7.18x	478.45x
EV/Sales	6.36x	434.33x
EV/EBITDA	23.24x	0.00x
P/B Ratio	8.16x	3.80x
P/FCF Ratio	39.14x	N/A
EV/FCF	34.70x	-4.21x
PEG Ratio	0.31x	N/A
Forward P/E (NTM)	57.50x	54.46x
Forward P/S (NTM)	6.55x	31.07x
Revenue & Growth
Revenue (TTM)	$458M	$3M
Revenue Growth (YoY)	34.4%	N/A
Forward Rev Growth	7.0%	32.1%
Profitability
Gross Margin (TTM)	70.6%	0.0%
Operating Margin (TTM)	23.6%	0.0%
EBITDA Margin (TTM)	27.4%	-41799.5%
Net Margin (TTM)	24.2%	-44523.2%
FCF Margin (TTM)	18.3%	-10320.0%
Net Income (TTM)	$111M	$-1.39B
FCF (TTM)	$84M	$-323M
EPS (TTM)	$2.08	-$8.94
ROE (TTM)	32.8%	0.0%
ROA (TTM)	24.8%	0.0%
ROIC (TTM)	32.8%	0.0%
Financial Health
Cash	$374M	$138M
Debt	$0	$0
Net Cash/Debt	$374M	$138M
Current Ratio (TTM)	4.58x	41.62x
Quick Ratio (TTM)	4.35x	37.77x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.58	1.09
52W Performance	330.5%	184.9%
YTD Performance	232.7%	223.0%
% from 52W High	-12.2%	-24.7%
% from 52W Low	356.4%	269.1%
Efficiency & Yields
Asset Turnover (TTM)	1.02x	0.00x
FCF Yield (TTM)	2.6%	-21.6%
Earnings Yield (TTM)	3.4%	-93.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	52.7	-10,320.0
EV/GP/RG	0.94	N/A
Ticker research	View CDNA research	View PURR research

Valuation

P/E Ratio

CDNA

30.64x

P/S Ratio

CDNA

7.18x

PURR

478.45x

EV/FCF

PURR

-4.21x

CDNA

34.70x

Growth & revenue

Revenue Growth TTM

CDNA

34.4%

Forward Revenue Growth

PURR

32.1%

CDNA

7.0%

Profitability & performance

Gross Margin

CDNA

70.6%

PURR

0.0%

ROE

CDNA

32.8%

PURR

0.0%

FCF Yield %

CDNA

2.6%

PURR

-21.6%

52-Week Performance

CDNA

330.5%

PURR

184.9%

Detailed metrics comparison

CDNA

CareDx Inc

PURR

Hyperliquid Strategies Inc

Market Cap

CDNA$3.29B

PURR$1.50B

Enterprise Value

CDNA$2.92B

PURR$1.36B

Price

CDNA$63.67

PURR$11.11

P/E Ratio

CDNA30.64x

PURRN/A

P/S Ratio

CDNA7.18x

PURR478.45x

EV/Sales

CDNA6.36x

PURR434.33x

EV/EBITDA

CDNA23.24x

PURR0.00x

P/B Ratio

CDNA8.16x

PURR3.80x

P/FCF Ratio

CDNA39.14x

PURRN/A

EV/FCF

CDNA34.70x

PURR-4.21x

PEG Ratio

CDNA0.31x

PURRN/A

Forward P/E (NTM)

CDNA57.50x

PURR54.46x

Forward P/S (NTM)

CDNA6.55x

PURR31.07x

Revenue (TTM)

CDNA$458M

PURR$3M

Revenue Growth (YoY)

CDNA34.4%

PURRN/A

Forward Rev Growth

CDNA7.0%

PURR32.1%

Gross Margin (TTM)

CDNA70.6%

PURR0.0%

Operating Margin (TTM)

CDNA23.6%

PURR0.0%

EBITDA Margin (TTM)

CDNA27.4%

PURR-41799.5%

Net Margin (TTM)

CDNA24.2%

PURR-44523.2%

FCF Margin (TTM)

CDNA18.3%

PURR-10320.0%

Net Income (TTM)

CDNA$111M

PURR$-1.39B

FCF (TTM)

CDNA$84M

PURR$-323M

EPS (TTM)

CDNA$2.08

PURR-$8.94

ROE (TTM)

CDNA32.8%

PURR0.0%

ROA (TTM)

CDNA24.8%

PURR0.0%

ROIC (TTM)

CDNA32.8%

PURR0.0%

Cash

CDNA$374M

PURR$138M

Debt

CDNA$0

PURR$0

Net Cash/Debt

CDNA$374M

PURR$138M

Current Ratio (TTM)

CDNA4.58x

PURR41.62x

Quick Ratio (TTM)

CDNA4.35x

PURR37.77x

Debt/Equity (TTM)

CDNA0.00x

PURR0.00x

Debt/Assets (TTM)

CDNA0.0%

PURR0.0%

Interest Coverage (TTM)

CDNAN/A

PURRN/A

Net Debt/EBITDA (TTM)

CDNA0.00x

PURR0.00x

Beta

CDNA2.58

PURR1.09

52W Performance

CDNA330.5%

PURR184.9%

YTD Performance

CDNA232.7%

PURR223.0%

% from 52W High

CDNA-12.2%

PURR-24.7%

% from 52W Low

CDNA356.4%

PURR269.1%

Asset Turnover (TTM)

CDNA1.02x

PURR0.00x

FCF Yield (TTM)

CDNA2.6%

PURR-21.6%

Earnings Yield (TTM)

CDNA3.4%

PURR-93.1%

Dividend Yield (TTM)

CDNAN/A

PURRN/A

Rule of 40

CDNA52.7

PURR-10,320.0

EV/GP/RG

CDNA0.94

PURRN/A

Ticker research

View CDNA research View PURR research

Metric	CDNA CareDx Inc	PURR Hyperliquid Strategies Inc
Market & Valuation
Market Cap	$3.29B	$1.50B
Enterprise Value	$2.92B	$1.36B
Price	$63.67	$11.11
P/E Ratio	30.64x	N/A
P/S Ratio	7.18x	478.45x
EV/Sales	6.36x	434.33x
EV/EBITDA	23.24x	0.00x
P/B Ratio	8.16x	3.80x
P/FCF Ratio	39.14x	N/A
EV/FCF	34.70x	-4.21x
PEG Ratio	0.31x	N/A
Forward P/E (NTM)	57.50x	54.46x
Forward P/S (NTM)	6.55x	31.07x
Revenue & Growth
Revenue (TTM)	$458M	$3M
Revenue Growth (YoY)	34.4%	N/A
Forward Rev Growth	7.0%	32.1%
Profitability
Gross Margin (TTM)	70.6%	0.0%
Operating Margin (TTM)	23.6%	0.0%
EBITDA Margin (TTM)	27.4%	-41799.5%
Net Margin (TTM)	24.2%	-44523.2%
FCF Margin (TTM)	18.3%	-10320.0%
Net Income (TTM)	$111M	$-1.39B
FCF (TTM)	$84M	$-323M
EPS (TTM)	$2.08	-$8.94
ROE (TTM)	32.8%	0.0%
ROA (TTM)	24.8%	0.0%
ROIC (TTM)	32.8%	0.0%
Financial Health
Cash	$374M	$138M
Debt	$0	$0
Net Cash/Debt	$374M	$138M
Current Ratio (TTM)	4.58x	41.62x
Quick Ratio (TTM)	4.35x	37.77x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.58	1.09
52W Performance	330.5%	184.9%
YTD Performance	232.7%	223.0%
% from 52W High	-12.2%	-24.7%
% from 52W Low	356.4%	269.1%
Efficiency & Yields
Asset Turnover (TTM)	1.02x	0.00x
FCF Yield (TTM)	2.6%	-21.6%
Earnings Yield (TTM)	3.4%	-93.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	52.7	-10,320.0
EV/GP/RG	0.94	N/A
Ticker research	View CDNA research	View PURR research